Technical Analysis for AKRX - Akorn, Inc.

Grade Last Price % Change Price Change
grade F 1.35 -4.26% -0.06
AKRX closed down 4.26 percent on Friday, January 17, 2020, on 83 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Down Down Flat
Historical AKRX trend table...

Date Alert Name Type % Chg

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic ophthalmic pharmaceuticals products, hospital drugs, and injectable pharmaceuticals in the United States and internationally. It offers products in various specialty areas, including ophthalmology, antidotes, anti-infectives, pain management, anesthesia, and vaccines. The company's Ophthalmic segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, angiography dyes, and others primarily for use in the office setting. This segment also offers therapeutic products, such as antibiotics, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers; and non-pharmaceutical products, which include various artificial tear solutions, preservative-free lubricating ointments, and eyelid cleansers. In addition, the Ophthalmic segment provides a line of over-the-counter dry eye and other eye health products principally under the TheraTears brand name through a chain drug stores and big box retailers, as well as directly to optometrists, ophthalmologists, and other eye care practitioners and clinics. Its Hospital Drugs & Injectables segment provides a line of hospital drug and injectable pharmaceutical products comprising antidotes, anti-infectives, controlled substances for pain management and anesthesia, and other pharmaceutical products to hospitals through the wholesale distribution channel. The company's Contract Services segment manufactures ophthalmic and injectable pharmaceutical products for third party pharmaceutical customers based on their specifications. It serves physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains, and other pharmaceutical companies. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois.
Medicine Health Pharmaceutical Pharmacy Pharmaceutical Products Pharmaceutical Industry In China Pain Management Antibiotics Cnx Nifty Glaucoma Therapeutic Products Ophthalmology Anti Infectives Optometry Eye Health Products Injectable Pharmaceuticals Non Pharmaceutical Products Ophthalmic

Is AKRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.46
52 Week Low 1.19
Average Volume 2,673,146
200-Day Moving Average 3.59
50-Day Moving Average 2.87
20-Day Moving Average 1.44
10-Day Moving Average 1.35
Average True Range 0.19
ADX 52.22
+DI 14.64
-DI 31.20
Chandelier Exit (Long, 3 ATRs ) 2.74
Chandelier Exit (Short, 3 ATRs ) 1.75
Upper Bollinger Band 1.79
Lower Bollinger Band 1.09
Percent B (%b) 0.37
BandWidth 48.50
MACD Line -0.44
MACD Signal Line -0.53
MACD Histogram 0.0922
Fundamentals Value
Market Cap 168.54 Million
Num Shares 125 Million
EPS 0.99
Price-to-Earnings (P/E) Ratio 1.36
Price-to-Sales 4.02
Price-to-Book 4.63
PEG Ratio -4.09
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.59
Resistance 3 (R3) 1.61 1.55 1.55
Resistance 2 (R2) 1.55 1.49 1.54 1.54
Resistance 1 (R1) 1.45 1.45 1.42 1.43 1.52
Pivot Point 1.39 1.39 1.38 1.38 1.39
Support 1 (S1) 1.29 1.33 1.26 1.27 1.18
Support 2 (S2) 1.23 1.29 1.22 1.16
Support 3 (S3) 1.13 1.23 1.15
Support 4 (S4) 1.11